MedicaidCoverageMedium impact
Continuous Subcutaneous Insulin External Infusion Pump - MEDICAID - LOUISIANA (New)
Humana·LA · Endocrinology, Family Medicine, Internal Medicine +1 more·Pharmacy
Effective date
May 18, 2026
We identified it
Jun 24, 2026
Summary
This is a new policy establishing coverage criteria for continuous subcutaneous insulin infusion pumps for Louisiana Medicaid members with Type 1 diabetes. The policy outlines specific eligibility requirements including diabetes education completion, multiple daily injections history, and glucose monitoring frequency.
Action Required
Before May 18, 2026: Billing team must establish procedures for insulin pump claims under Louisiana Medicaid DMEPOS program. Ensure providers document completion of diabetes education, 6-month multiple daily injection history, glucose self-testing frequency (4+ times daily), and autoantibody or C-peptide testing results. Claims without proper documentation will be denied.